RESEARCH USE ONLY: These products are strictly for laboratory research purposes and not for human consumption.
NAD+
Nicotinamide Adenine Dinucleotide
Compound Profile
C₂₁H₂₈N₇O₁₄P₂⁺
663.4 g/mol
For maximum stability, store the lyophilized powder at -20°C (or -80°C for long-term preservation) protected from light and moisture. Once reconstituted with bacteriostatic water or sterile saline, the solution should be kept refrigerated at 2°C to 8°C and utilized within 14–21 days. Avoid repeated freeze-thaw cycles and keep vials tightly sealed until use to maintain compound integrity.
Relevant Literature
Recent in-vitro studies:
Selected in-vitro / cell-based PubMed literature relevant to this compound:
- Reference 1
A Nikiforov et al. (2011). Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem. PMID: 21504897.
View on PubMed - Reference 2
V Kulikova et al. (2019). Degradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells. Metabolites. PMID: 31795381.
View on PubMed - Reference 3
S Kang et al. (2024). Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD+) by Synergistic Inhibition of CD38 Expression. Int J Mol Sci. PMID: 39513906.
View on PubMed
